Fig. 1: Homozygous TBC1D4 p.Arg684Ter variant carriers display prolonged hyperglycaemia followed by hypoglycaemia during an extended oral glucose challenge.

a, Graphical representation of the OGTT. b–i, Blood glucose (b) as well as plasma C-peptide (c), insulin (d), glucagon (e), adrenaline (f), noradrenaline (g), cortisol (h) and growth hormone (i) during an extended (6 h) OGTT. *Difference between TBC1D4 carriers and Controls at the given time point. ‡Different from basal (time 0) within the same group. One symbol P < 0.05. Two symbols P < 0.01. Three symbols P < 0.001. Symbols within parentheses represent P values between 0.1 and 0.05. n = 8 in Controls and n = 7 in TBC1D4 carriers. Data are means ± s.e.m. Data were analysed using a two-way repeated ANOVA test (one factor repeated) and two-tailed Student–Newman–Keuls post hoc analyses for multiple comparisons. Graphics in a created using BioRender.com.